New Delhi:Three new AIIMS to come up at Mangalagiri near Guntur in Andhra Pradesh, Nagpur in Maharashtra & Kalyani in West Bengal at the cost of Rs. 1618 crore,Rs 1577 crore & Rs. 1754 respectively. The projects have received the centres approval under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) involving a total financial implication of Rs. 4949 crore. An announcement to this effect was made by Mr. JP Nadda, Health Minister in the Rajya Sabha today.
The projects are supposed to reach completion within a period of 60 months from the date of commencement, comprising of a 12 month pre- construction phase, a construction period of 42 months and a stabilization phase of 60 months.
According to Nadda each institution will have an intake of 100 under-graduate students and will impart PG/Doctoral courses in various disciplines. The projects also have provisions for Nursing Colleges with programmes in B.Sc (Nursing) and M.Sc (Nursing) students.The total bed strength coming to 960 beds, with 42 speciality/super-speciality departments.
The three AIIMS establishments would also consists of speciality, super speciality, basic science and other departments.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!